Skip to content

Japanese Catheter Ablation Registry

Japanese Catheter Ablation Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03729232
Acronym
J-AB
Enrollment
400000
Registered
2018-11-02
Start date
2017-07-01
Completion date
2030-03-31
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmias, Catheter Ablation

Keywords

Catheter Ablation, Cardiac Arrhythmias, Registry, Complication, REDCap

Brief summary

Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.

Detailed description

Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and Cardiovascular Center. This study is a voluntary nationwide registry and data are collected prospectively using a Research Electronic Data Capture (REDCap) system. Detailed data collection including antiarrhythmic medication is also performed at every September. The acute success rate at discharge and the complications associated with ablation procedure will be collected in all cases. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria. Based on the provided information, the annual incidence and predictive factors for outcome will be investigated by the event assessment committee.

Interventions

None listed

Sponsors

National Cerebral and Cardiovascular Center, Japan
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients treated with catheter ablation in Japan

Exclusion criteria

* Patients who refused to consent

Design outcomes

Primary

MeasureTime frame
Number of patients with recurrence of targeted arrhythmiaThrough discharge from hospital, approximately up to 1 weeks

Secondary

MeasureTime frameDescription
Number of deathsThrough discharge from hospital, approximately up to 1 weeksAll-cause death, cardiovascular death, and procedure-related death
Number of patients with treatment-related complications3 monthsBleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.

Countries

Japan

Contacts

Primary ContactKengo Kusano, MD, PhD
kusanokengo@ncvc.go.jp+81-6-6170-1070
Backup ContactMisa Takegami, PhD, MPH
takegami@ncvc.go.jp+81-6-6170-1070

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026